Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-48,400
Closed -$3.56M 168
2023
Q4
$3.56M Buy
48,400
+47,877
+9,154% +$2.96M 0.33% 70
2023
Q3
$2.4M Buy
+523
New +$23.2K 0.29% 76

Other funds holding NUVL

Ikarian Capital's NUVL Position: Q1 2026 in Review

Ikarian Capital reduced its Nuvalent (NUVL) stake by 60% in Q1 2026, selling an estimated $3.67M and leaving 23,594 shares worth $2.42M. The position accounts for 0.2% of the portfolio, ranked #92.

Ikarian Capital first reported a position in NUVL in Q2 2023 and has held it in 9 quarters since. The position peaked at $19M in Q4 2023. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Ikarian Capital held 23,594 shares of Nuvalent worth $2.42M as of Q1 2026.
  • Ikarian Capital sold 36,000 Nuvalent shares in Q1 2026, an estimated $3.67M.
  • Nuvalent made up 0.2% of Ikarian Capital's portfolio in Q1 2026, its #92 holding.
  • Ikarian Capital first reported a position in Nuvalent in Q2 2023 and has held it in 9 quarters since.
  • Ikarian Capital's Nuvalent position peaked at $19M in Q4 2023.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.